Granite FO LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Hold
400
0.01% 88
2026
Q1
$25.1K Hold
400
0.01% 85
2025
Q4
$38.1K Sell
400
-2,000
-83% -$196K 0.02% 85
2025
Q3
$234K Hold
2,400
0.13% 45
2025
Q2
$258K Hold
2,400
0.15% 43
2025
Q1
$242K Hold
2,400
0.14% 42
2024
Q4
$214K Hold
2,400
0.12% 45
2024
Q3
$201K Buy
+2,400
New +$189K 0.11% 51
2024
Q2
Sell
-2,400
Closed -$191K 79
2024
Q1
$191K Hold
2,400
0.11% 54
2023
Q4
$139K Hold
2,400
0.09% 63
2023
Q3
$127K Hold
2,400
0.09% 63
2023
Q2
$130K Sell
2,400
-4,600
-66% -$240K 0.09% 69
2023
Q1
$365K Buy
+7,000
New +$330K 0.23% 50

Other funds holding BSX

Granite FO LLC's BSX Position: Q2 2026 in Review

Granite FO LLC held its Boston Scientific (BSX) position steady in Q2 2026 at 400 shares worth $17.1K. The position accounts for 0.01% of the portfolio, ranked #88.

Granite FO LLC first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $365K in Q1 2023. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Granite FO LLC held 400 shares of Boston Scientific worth $17.1K as of Q2 2026.
  • Granite FO LLC left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Granite FO LLC's portfolio in Q2 2026, its #88 holding.
  • Granite FO LLC first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
  • Granite FO LLC's Boston Scientific position peaked at $365K in Q1 2023.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Granite FO LLC's 13F filing for Q2 2026, filed 15 Jul 2026.